Does smoking influence survival in cancer patients through effects on respiratory and vascular disease?

被引:10
作者
Clark, TG
Murphy, MFG
Hey, K
Drury, M
Cheng, KK
Aveyard, P [1 ]
机构
[1] Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England
[2] Univ Oxford, Ctr Stat Med, Oxford, England
[3] Radcliffe Infirm, Canc Res UK Gen Practice Res Grp, Dept Clin Pharmacol, Oxford OX2 6HE, England
[4] Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham, W Midlands, England
关键词
cancer; cardiovascular disease; prognosis; respiratory disease; smoking cessation;
D O I
10.1097/01.cej.0000186634.81753.45
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Patients with cancers caused by smoking may die because they continue to smoke even after diagnosis of a cancer caused by smoking. We investigated differences in cause-specific mortality between patients diagnosed with smoking-related and non-smoking-related cancers. The causes of death were classified as smoking-related cancer, nonsmoking-related cancer, respiratory or vascular disease, and all other causes. We studied all 220089 people diagnosed with cancer in Scotland between 1986 and 1996, aged between 20 and 85 years, with last follow-up on 31 December 1999. There was a moderate excess risk of dying from respiratory and vascular causes in those with smoking-related cancers, which did not fall with time since diagnosis, consistent with continued smoking by these patients. Mortality among cancer patients might fall if more assistance in stopping smoking was provided for patients who have smoking-related cancers.
引用
收藏
页码:87 / 90
页数:4
相关论文
共 13 条
[1]
Does smoking status influence the prognosis of bladder cancer? A systematic review [J].
Aveyard, P ;
Adab, P ;
Cheng, KK ;
Wallace, DMA ;
Hey, K ;
Murphy, MFG .
BJU INTERNATIONAL, 2002, 90 (03) :228-239
[2]
Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials [J].
Early Breast Cancer Trialists' Collaborative Group .
LANCET, 2000, 355 (9217) :1757-1770
[3]
Gonzalez M, 2000, CLIN ONCOL-UK, V12, P195
[4]
GRITZ ER, 2003, IN PRESS EVIDENCE BA
[5]
Pulmonary and cardiovascular consequences of smoking [J].
Kamholz, SL .
MEDICAL CLINICS OF NORTH AMERICA, 2004, 88 (06) :1415-+
[6]
Khuri FR, 2001, CANCER EPIDEM BIOMAR, V10, P823
[7]
APPLYING COX REGRESSION TO COMPETING RISKS [J].
LUNN, M ;
MCNEIL, N .
BIOMETRICS, 1995, 51 (02) :524-532
[8]
Interventions for smoking cessation in hospitalised patients:: a systematic review [J].
Munafò, M ;
Rigotti, N ;
Lancaster, T ;
Stead, L ;
Murphy, M .
THORAX, 2001, 56 (08) :656-663
[9]
THE HEALTH BENEFITS OF SMOKING CESSATION [J].
SAMET, JM .
MEDICAL CLINICS OF NORTH AMERICA, 1992, 76 (02) :399-414
[10]
Sioris T, 2000, INT J CANCER, V86, P590, DOI 10.1002/(SICI)1097-0215(20000515)86:4<590::AID-IJC23>3.0.CO